Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

96 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Immunologic Gene Signature Analysis Correlates Myeloid Cells and M2 Macrophages with Time to Trabectedin Failure in Sarcoma Patients.
Schroeder BA, Zhang Y, Smythe KS, Desai P, Thomas A, Viveiros P, Alexiev BA, Obeidin F, Chen EY, Cranmer LD, Wagner MJ, Jones RL, Campbell JS, Pierce RH, He Q, Pollack SM. Schroeder BA, et al. Among authors: pollack sm. Cancers (Basel). 2022 Mar 2;14(5):1290. doi: 10.3390/cancers14051290. Cancers (Basel). 2022. PMID: 35267598 Free PMC article.
B7-H3 Specific CAR T Cells for the Naturally Occurring, Spontaneous Canine Sarcoma Model.
Zhang S, Black RG, Kohli K, Hayes BJ, Miller C, Koehne A, Schroeder BA, Abrams K, Schulte BC, Alexiev BA, Heimberger AB, Zhang A, Jing W, Ng JCK, Shinglot H, Seguin B, Salter AI, Riddell SR, Jensen MC, Gottschalk S, Moore PF, Torok-Storb B, Pollack SM. Zhang S, et al. Among authors: pollack sm. Mol Cancer Ther. 2022 Jun 1;21(6):999-1009. doi: 10.1158/1535-7163.MCT-21-0726. Mol Cancer Ther. 2022. PMID: 35405743 Free PMC article.
Immune Assessment Today: Optimizing and Standardizing Efforts to Monitor Immune Responses in Cancer and Beyond.
Pandey S, Cholak ME, Yadali R, Sosman JA, Tetreault MP, Fang D, Pollack SM, Gnjatic S, Obeng RC, Lyerly HK, Sonabend AM, Guevara-Patiño JA, Butterfield LH, Zhang B, Maecker HT, Le Poole IC. Pandey S, et al. Among authors: pollack sm. Cancers (Basel). 2024 Jan 23;16(3):475. doi: 10.3390/cancers16030475. Cancers (Basel). 2024. PMID: 38339227 Free PMC article.
Unmet Medical Needs and Future Perspectives for Leiomyosarcoma Patients-A Position Paper from the National LeioMyoSarcoma Foundation (NLMSF) and Sarcoma Patients EuroNet (SPAEN).
Kasper B, Achee A, Schuster K, Wilson R, van Oortmerssen G, Gladdy RA, Hemming ML, Huang P, Ingham M, Jones RL, Pollack SM, Reinke D, Sanfilippo R, Schuetze SM, Somaiah N, Van Tine BA, Wilky B, Okuno S, Trent J. Kasper B, et al. Among authors: pollack sm. Cancers (Basel). 2021 Feb 20;13(4):886. doi: 10.3390/cancers13040886. Cancers (Basel). 2021. PMID: 33672607 Free PMC article. Review.
Optimising Cancer Vaccine Design in Sarcoma.
Pender A, Jones RL, Pollack S. Pender A, et al. Cancers (Basel). 2018 Dec 20;11(1):1. doi: 10.3390/cancers11010001. Cancers (Basel). 2018. PMID: 30577459 Free PMC article. Review.
IL-15 mediated expansion of rare durable memory T cells following adoptive cellular therapy.
Kohli K, Yao L, Nowicki TS, Zhang S, Black RG, Schroeder BA, Farrar EA, Cao J, Sloan H, Stief D, Cranmer LD, Wagner MJ, Hawkins DS, Pillarisetty VG, Ribas A, Campbell J, Pierce RH, Kim EY, Jones RL, Riddell SR, Yee C, Pollack SM. Kohli K, et al. Among authors: pollack sm. J Immunother Cancer. 2021 May;9(5):e002232. doi: 10.1136/jitc-2020-002232. J Immunother Cancer. 2021. PMID: 33963013 Free PMC article. Clinical Trial.
Immunotherapy of sarcomas with modified T cells.
Mahalingam P, Julve M, Huang P, Furness AJS, Pollack SM, Jones RL. Mahalingam P, et al. Among authors: pollack sm. Curr Opin Oncol. 2022 Jul 1;34(4):362-370. doi: 10.1097/CCO.0000000000000843. Curr Opin Oncol. 2022. PMID: 35837706 Review.
Combinations of Chemotherapy and PD-1/PD-L1 Inhibitors in Sarcoma.
Lynch MM, Alexiev BA, Schroeder BA, Pollack SM. Lynch MM, et al. Among authors: pollack sm. Curr Treat Options Oncol. 2022 Dec;23(12):1861-1876. doi: 10.1007/s11864-022-01036-1. Epub 2022 Nov 16. Curr Treat Options Oncol. 2022. PMID: 36380108 Review.
Systemic Anti-Cancer Therapy in Synovial Sarcoma: A Systematic Review.
Riedel RF, Jones RL, Italiano A, Bohac C, Thompson JC, Mueller K, Khan Z, Pollack SM, Van Tine BA. Riedel RF, et al. Among authors: pollack sm. Cancers (Basel). 2018 Nov 1;10(11):417. doi: 10.3390/cancers10110417. Cancers (Basel). 2018. PMID: 30388821 Free PMC article. Review.
96 results